American Association for Cancer Research

Poster Session B

Poster Session B
Saturday, November 5
1:00 p.m.-3:00 p.m.

In alphabetical order, not board assignment order

  • A novel population of bone marrow-derived cells normalizes tumor vasculature and inhibits tumor progression, Alessandro Carrer, International Center for Genetic Engineering and Biotechnology, Trieste, Italy
  • A p53FRT mouse to generate tumors by Flp recombinase to allow for manipulation of the tumor microenvironment by Cre recombinase, Everett Moding, Duke University Medical Center, Durham, NC, United States
  • Antibiotics administration alters the microenvironment and impairs responsiveness to CpG-based immunotherapy in murine tumors, Noriho Iida, Cancer and Inflammation Program, National Cancer Institute, National Institutes of Health, Frederick, MD, United States
  • Apolipoprotein A-I mimetic peptides, L-4F and L-5F, inhibit expression and activity of hypoxia-inducible factor 1α in human ovarian cancer cells and in a mouse model of ovarian cancer, Feng Gao, UCLA, Los Angeles, CA, United States
  • Bone marrow- and tumor-derived mesenchymal cells stimulate survival and invasion of colorectal cancer cells through paracrine neuregulin-1/HER3 signaling., Astrid De Boeck, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium
  • Bone marrow reserve of MSC in untreated advanced breast cancer patients: A reservoir of the disease, Valeria Fernandez Vallone, Institute for Experimental Biology and Medicine, Buenos Aires, Argentina
  • Cancer associated fibroblasts in human breast carcinomas promote cancer cell proliferation and migration through increased TGF-α, Ming-Qing Gao, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea (Rep.)
  • CD24+ phenotype of Ovarian cancer cells is associated with invasive properties, Kyu Sub Kang, Yonsei University College of Medicine, Seoul, Korea (Rep.)
  • CD44 mediates mesenchymal stem cell migration and incorporation into the tumor microenvironment as tumor associated fibroblasts, Erika Spaeth, MD Anderson Cancer Center, Houston, TX, United States
  • Characterization of Matrix Gla Protein (MGP) in Vascular Function and Angiogenesis, Bikram Sharma, Indiana State University, Terre Haute, Indiana, United States
  • Collagen type I released by hepatic stellate cell contributes to hepatoma cell undergo epithelial-mesenchymal transition in murine model, Ming-Chen Yang, Department of Microbiology & Immunology, National Cheng Kung University, Tainan, Taiwan
  • Connective Tissue Growth Factor (CTGF) contributes to microenvironment interactions in childhood leukemia, Julia Wells, University of Western Australia, Perth, WA, Australia
  • Decellularized Rat Matrix Selects Highly Invasive Human A549 Lung Cancer Cells, Min Kim, The Methodist Hospital, Houston, TX, United States
  • Defining mesenchymal myofibroblast progenitor cells in prostate cancer: Mechanisms of Transforming Growth Factor β1-induced myofibroblast differentiation, Woosook Kim, Baylor College of Medicine, Houston, Texas, United States
  • Depletion of fibroblast activation protein-α expressing cells during cancer progression is associated with the development of cancer cachexia in the mouse, Ed Roberts, University of Cambridge, Cambridge, England
  • Development of enhanced models of breast cancer brain metastasis for the evaluation of oncolytic viral therapy using a herpes simplex virus that expresses interleukin-12, James Cody, University of Alabama, Birmingham, AL, United States
  • Differential regulation of glucose metabolism by HIF in pancreatic tumor cells and stromal cells at distinct metastatic loci, Pankaj Singh, Eppley Institute for Cancer Research, UNMC, Omaha, NE, United States
  • Eμ-c-myc B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma, Alanna Ruddell, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
  • Effects of ginger derived substances on MDA-MB-231 tumor cells., Marcia Cominetti, Federal University of Sao Carlos, Sao Carlos, SP, Brazil
  • Elucidation of the age-related changes in the stromal compartment that impact tumorigenesis, Sheila Stewart, Washington University in St. Louis, St. Louis, MO, United States
  • EphrinB2 regulates tumor immune microenvironments, Kenneth Cohen, University of Chicago, Chicago, IL, United States
  • Exosome vesicles constitute a novel mediator of hypoxic signaling in glioblastoma, Mattias Belting, Lund University, Lund, Sweden
  • Expression of cysteine protease cathepsin K by oral tongue squamous cell carcinomas in vivo and in vitro, Carolina Bitu, University of Oulu, Oulu, Finland
  • Fluoxetine enhances the development of breast tumor metastasis in the brain., Yuriy Shapovalov, University of Rochester, Rochester, NY, United States
  • Getting old and misbehaving: Can stromal aging drive melanoma initiation?, Eunjung Kim, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
  • GRK2 antagonizes pro-malignant properties of breast cancer cells and pro-angiogenic properties of vascular smooth muscle cells, Jimin Guo, McGill University Health Center, Montreal, Quebec, Canada
  • High-throughput proteomics reveals novel mediators of ovarian cancer and peritoneal mesothelial cell interaction during metastasis in an in vitro co-culture model, Natasha Musrap, University of Toronto, Toronto, ON, Canada
  • Human ovarian carcinoma associate MSCs (CA-MSC) are Hedgehog responsive and promote tumor growth by increasing ovarian cancer stem cell proportion, y
  • Yunjung Choi, University of Michigan, Ann Arbor, MI, United States
  • Hypoxia and cancer initiating cells in carcinoma of the cervix, Delphine Marie-Egyptienne, Ontario Cancer Inst./Princess Margaret Hospital and Campbell Family Inst. for Cancer Research, Toronto, ON, Canada
  • Identification of a secretory stromal gene signature of the ovarian tumor microenvironment and implications for ovarian cancer progression via SFRP2, Melissa Thompson, University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • Importance of OPG, RANKL and TRAIL in breast tumor growth, Leandro Martinez, Experimental Medicine and Biological Institute, Buenos Aires, Argentina
  • In vitro study of tumor cell adhesion to and transmigration across an endothelial monolayer using microfluidics, Jessie Jeon, MIT, Cambridge, MA, United States
  • Integrin α3β1-dependent mRNA regulation of human breast cancer genes, Sita Subbaram, Albany Medical College, Albany, NY, United States
  • LPA-dependent regulation of VCAM-1 in the ovarian cancer metastatic microenvironment and its impact on mesothelial invasion, Timothy Raines, University of Virginia, Charlottesville, VA, United States
  • Metadherin mediates tumor migration and interaction with non-cellular matrix stromal elements in osteosarcoma, Dennis Hughes, University of Texas MD Anderson Cancer Center, Houston, Texas, United States
  • Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2, Ching-Chow Chen, Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
  • Microenvironmental TGFβ increases the expression of both EMT and stem cells markers in Oral squamous cell carcinoma, Amani Osman, Gades institute UiB, Bergen, Hordaland, Norway
  • Modeling the tumor vascular microenvironment using microfluidics: Live imaging of tumor cell invasion dynamics and endothelial barrier function, Ioannis Zervantonakis, Massachusetts Institute of Technology, Cambridge, MA, United States
  • Neuropilin-2 is upregulated during EMT in lung cancer, Patrick Nasarre, Medical University of South Carolina, Charleston, SC, United States
  • Niche-dependent self-renewal and tumorigenic differentiation of malignant ovarian ascites- derived cancer cell subpopulations, Maty Tzukerman, Faculty of Medicine, Technion-Israel Insti, Haifa, , Israel
  • Nogo-B receptor (NgBR) is a new therapeutic target for increasing the sensitivity of breast cancer to chemotherapy and irradiation, Baofeng Zhao, Medical College of Wisconsin, Milwaukee, WI, United States
  • Novel stromal angiogenic factor MFAP5 in ovarian cancer progression, Cecilia Leung, University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • Precise Characterization of Stromal Transcriptional Response to Developing Tumors Using RNAseq, Russell Bainer, The University of Chicago, Chicago, IL, United States
  • Prostate cancer-derived exosomes as a mechanism of immune evasion, Marie Lundholm, Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
  • Proteomic analysis of desmoplastic cocultures reveals collagen XII, as a putative marker of myofibroblastic induction during colorectal cancer metastasis, George Karagiannis, University of Toronto, Toronto, ON, Canada
  • PTN-ALK signaling promotes an anti-inflammatory and pro-metastatic macrophage phenotype in murine models of breast cancer, Rolf Brekken, UT Southwestern Medical Center, Dallas, TX, United States
  • Reprogramming the immune environment in breast cancer via dendritic cells, Te-Chia Wu, Baylor institute for immunology research, Dallas, TX, United States
  • Role of intratumoral hypoxia on Tenascin C expression in oropharyngeal cancer, Abraham Schneider, University of Maryland, Baltimore, MD, United States
  • Selective blockade of adenosinergic effects in the tumor microenvironment, Bin Zhang, University of Texas Health Science Center, San Antonio, TX, United States
  • Stromal SPARC critically regulates secondary lymphoid tissues homeostasis and has a role in B lymphoma development, Sabina Sangaletti, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • TGF-beta regulated stromal versican modifies tumor microenvironment and promotes cancer invasion in advanced stage serous ovarian cancer, Tsz-Lun Yeung, University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • The effects of Vegfs on macrophages, Thomas Wirth, University of Eastern Finland, Kuopio, Finland
  • The expression of α-SMA+ cells as a biomarker for predicting response to bevacizumab, Chang Hwan Ryu, Department of otolaryngology, University of Ulsan College of Medicine, Asan medical center, Seoul, Korea (Rep.)
  • The IL-8/IL-8 receptor axis plays a significant role in the epithelial-mesenchymal phenotypic switch of human carcinoma cells, Romaine Fernando, LTIB/NCI/NIH, Bethesda, MD, United States
  • The microenvironment plays an important role in the ability of aerosol Gemcitabine and Liposomal 9-Nitrocamptothecin to elicit therapeutic effect on Osteosarcoma lung metastases., Nancy Gordon, MD Anderson Cancer Center, Houston, Texas, United States
  • The Role of miR-21 in Tumor-associated Macrophages, Yong Li, University of Louisville, Louisville, KY, United States
  • The tumor indicating normal tissue (TINT) that surrounds prostate tumors could be a novel source of diagnostic and prognostic markers., Hani Adamo, Pathology Bioscience department, Umeå, Sweden
  • The unfolded protein response downregulates expression of the angiogenesis inhibitor Thrombospondin-1, Goleeta Alam, University of Michigan, Ann Arbor, MI, United States
  • Therapeutic Topical Administration of HoxA5 in a Squamous Cell Carcinogenesis Model, Hans Layman, University of California, San Francisco, California, United States
  • Tissue-infiltrating pro-tumor neutrophils may contribute to the pre-metastatic niche, Kathryn Verbanac, The Brody School of Medicine at East Carolina University, Greenville, NC, United States
  • Tumor infiltration by naïve T cells is dependent on location of growth, presence of endogenous lymphocytes, and acquisition of lymphoid-like characteristics, David Peske, University of Virginia School of Medicine, Charlottesville, VA, United States
  • Tumor-associated lymphatic endothelial cells inhibit antigen-specific CD8+ T cell responses, Amanda Lund, Swiss Federal Institute of Technology, Lausanne, Switzerland
Poster Session A Poster Session B